Equity Based Incentive Compensation Plan (Tables)

12 Months Ended

Sep. 30, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of assumptions used in determining fair value of stock option

The assumptions used in determining the fair value of stock option grants for the year ended September 30, 2021 are as follows:

Weighted average fair value of awards	$	6.06
Risk-free rate		1.25	%
Dividend yield		—	%
Volatility		29.72	%
Expected life	6.5 years

The assumptions used in determining the fair value of stock option grants for the year ended September 30, 2020 are as follows:

Weighted average fair value of awards	$	4.72
Risk-free rate		1.22	%
Dividend yield		—	%
Volatility		19.86	%
Expected life	6.5 years

Schedule of stock option activity

The following is a summary of currently outstanding options at September 30, 2021:

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value
Outstanding, beginning of year		25,830	$	21.57			$	—
Granted		7,000	$	18.69			$	—
Exercised		—	$	—			$	—
Forfeited/cancelled/expired		—	$	—			$	—
Outstanding, end of year		32,830	$	20.96		7.392	$	1,940
Exercisable at end of year		13,310	$	21.53		6.193	$	1,940
Nonvested at end of year		19,520	$	20.56

The following is a summary of currently outstanding options at September 30, 2020:

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value
Outstanding, beginning of year		18,830	$	22.05			$	21,350
Granted		7,000	$	20.28			$	—
Exercised		—	$	—			$	—
Forfeited/cancelled/expired		—	$	—			$	—
Outstanding, end of year		25,830	$	21.57		7.819	$	—
Exercisable at end of year		8,140	$	21.50		6.794	$	—
Nonvested at end of year		17,690	$	21.60

Schedule of restricted stock outstanding

The table below summarizes the activity for the Company’s restricted stock outstanding at September 30, 2021:

	Shares			Weighted Average Fair Value
Outstanding, beginning of year		30,653		$	21.98
Granted		12,363			18.69
Vested		(11,530	)		20.82
Forfeited/cancelled/expired		—			—
Outstanding, end of year		31,486		$	21.10

The table below summarizes the activity for the Company’s restricted stock outstanding at September 30, 2020:

	Shares			Weighted Average Fair Value
Outstanding, beginning of year		18,493		$	21.78
Granted		23,821			19.62
Vested		(10,051	)		16.62
Forfeited/cancelled/expired		(1,610	)		21.43
Outstanding, end of year		30,653		$	21.98